Developing new antibiotics

Liz Meszaros, MDLinx

Superbugs and Superdrugs USA

Iselin, New Jersey, United States | November 13-14, 2017


Iselin, NJ, November 13, 2017--The development of new antibiotics is paramount to the functioning of modern medicine as we know it, said John H. Rex, MD, FACP, chief medical officer, F2G Ltd., Manchester, UK.

The socioeconomic impacts of not having new treatments available to fight antimicrobial resistance are both direct and indirect. Dr. Rex brilliantly compared the availability of new antibiotics to the availability of fire extinguishers: Both make existence more palatable, and although one hopes that they will not be necessary, their availability confers a general feeling of safety and confidence.